C43.39
Malignant melanoma of other parts of face
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant melanoma is a serious form of skin cancer that begins in the cells responsible for producing melanin, the pigment that gives skin its color. When it occurs on the face, particularly in areas not classified under more common categories, it falls under the code C43.39. This type of melanoma can develop in various regions of the face, excluding the more typical areas like the eyelids, lips, or ears, and often requires prompt medical attention for diagnosis and management. Despite being less common in certain facial regions, malignant melanoma can be aggressive and has the potential to spread to other parts of the body if not treated early.
Causes & Symptoms
Clinical Causes: Excessive exposure to ultraviolet (UV) radiation from the sun or tanning beds Having a fair complexion, light-colored eyes, or red hair, which increases susceptibility History of sunburns, especially during childhood Presence of many moles or atypical moles on the face Genetic predisposition to skin cancer Weakened immune system Previous history of skin cancer
Key Symptoms: A new or changing mole or pigmented lesion on the face Asymmetrical shape of a mole or lesion Irregular, scalloped, or poorly defined edges Color variations within the lesion, including browns, blacks, reds, whites, or blues A diameter larger than 6mm, although smaller lesions can also be malignant Itching, tenderness, or pain in the affected area Ulceration or bleeding from the lesion Changes in sensation or the appearance of a sore that doesn’t heal
Diagnostic & Treatment
Diagnosis Path: Diagnosis of malignant melanoma in the facial area involves a combination of clinical examination and diagnostic procedures. A dermatologist typically examines the lesion thoroughly, assessing its features using dermoscopy—an imaging technique that allows closer inspection of skin structures. If suspicion remains, a biopsy is performed, in which a sample of the lesion is removed and examined microscopically for cancer cells. Additional tests, such as sentinel lymph node biopsy or imaging scans, may be used to determine whether the melanoma has spread beyond the primary site. Early detection is crucial for effective treatment outcomes.
Treatment Protocols: Immunotherapy to stimulate the body's immune system to attack cancer cells Targeted therapy aimed at specific genetic mutations of the melanoma Radiation therapy, especially if surgery isn’t feasible or for advanced cases Chemotherapy in rare instances, though less common today due to advances in targeted treatments
Clinical Advice & FAQs
Billing Guidance
Is C43.39 a billable ICD-10 code?
Yes, C43.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C43.39?
Clinical documentation must specify the nature of Malignant melanoma of other parts of face and any associated comorbidities for accurate reporting.
Cite this Clinical Reference